Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals

Zürcher Kantonalbank has filed a Form 8.3 with the Irish Takeover Panel concerning its position in Avadel Pharmaceuticals plc. The disclosure, dated January 6, 2026, underlines the bank's interest in relevant securities, representing 0.04% of Avadel's ordinary shares, totaling 37,707 shares. This filing is in accordance with the Irish Takeover Panel Act, 1997, and Takeover Rules, 2022.

In addition to this, the bank reported no dealings in cash-settled derivatives, stock-settled derivatives, or any other securities transactions related to Avadel as of January 5, 2026. Furthermore, there are no other agreements or arrangements related to securities voting rights outside of regular title transfer dealings involving ordinary shares.

The form further noted that no exemptions as an exempt fund manager apply and no other parties to the offer are disclosed.